Che, Tao <br/><br/>
Nanobody-enabled monitoring of kappa opioid receptor states.  [electronic resource] 

 -  Nature communications  03 2020 
 - 1145 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/s41467-020-14889-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allosteric Site<br/>Binding Sites<br/>Biosensing Techniques<br/>Crystallography, X-Ray<br/>Cyclic AMP--metabolism<br/>Dynorphins--chemistry<br/>HEK293 Cells<br/>Humans<br/>Luminescent Measurements--methods<br/>Piperazines--chemistry<br/>Piperidines--chemistry<br/>Protein Conformation<br/>Pyrrolidines--chemistry<br/>Receptors, G-Protein-Coupled--chemistry<br/>Receptors, Opioid, kappa--agonists<br/>Recombinant Proteins--chemistry<br/>Single-Domain Antibodies--chemistry<br/>Tetrahydroisoquinolines--chemistry